57 related articles for article (PubMed ID: 29350066)
21. Sonic hedgehog (Shh) signaling promotes tumorigenicity and stemness via activation of epithelial-to-mesenchymal transition (EMT) in bladder cancer.
Islam SS; Mokhtari RB; Noman AS; Uddin M; Rahman MZ; Azadi MA; Zlotta A; van der Kwast T; Yeger H; Farhat WA
Mol Carcinog; 2016 May; 55(5):537-51. PubMed ID: 25728352
[TBL] [Abstract][Full Text] [Related]
22. Best practices recommendations in the application of immunohistochemistry in the bladder lesions: report from the International Society of Urologic Pathology consensus conference.
Amin MB; Trpkov K; Lopez-Beltran A; Grignon D;
Am J Surg Pathol; 2014 Aug; 38(8):e20-34. PubMed ID: 25029121
[TBL] [Abstract][Full Text] [Related]
23. DNA repair gene variants in relation to overall cancer risk: a population-based study.
Alberg AJ; Jorgensen TJ; Ruczinski I; Wheless L; Shugart YY; Berthier-Schaad Y; Kessing B; Hoffman-Bolton J; Helzlsouer KJ; Kao WH; Francis L; Alani RM; Smith MW; Strickland PT
Carcinogenesis; 2013 Jan; 34(1):86-92. PubMed ID: 23027618
[TBL] [Abstract][Full Text] [Related]
24. Normal and neoplastic urothelial stem cells: getting to the root of the problem.
Ho PL; Kurtova A; Chan KS
Nat Rev Urol; 2012 Oct; 9(10):583-94. PubMed ID: 22890301
[TBL] [Abstract][Full Text] [Related]
25. Stem cells in the biology of normal urothelium and urothelial carcinoma.
Hatina J; Schulz WA
Neoplasma; 2012; 59(6):728-36. PubMed ID: 22862174
[TBL] [Abstract][Full Text] [Related]
26. Review: BBN as an urothelial carcinogen.
Vasconcelos-Nóbrega C; Colaço A; Lopes C; Oliveira PA
In Vivo; 2012; 26(4):727-39. PubMed ID: 22773588
[TBL] [Abstract][Full Text] [Related]
27. Utility of cytokeratin 5/6, cytokeratin 20, and p16 in the diagnosis of reactive urothelial atypia and noninvasive component of urothelial neoplasia.
Edgecombe A; Nguyen BN; Djordjevic B; Belanger EC; Mai KT
Appl Immunohistochem Mol Morphol; 2012 May; 20(3):264-71. PubMed ID: 22498670
[TBL] [Abstract][Full Text] [Related]
28. Three differentiation states risk-stratify bladder cancer into distinct subtypes.
Volkmer JP; Sahoo D; Chin RK; Ho PL; Tang C; Kurtova AV; Willingham SB; Pazhanisamy SK; Contreras-Trujillo H; Storm TA; Lotan Y; Beck AH; Chung BI; Alizadeh AA; Godoy G; Lerner SP; van de Rijn M; Shortliffe LD; Weissman IL; Chan KS
Proc Natl Acad Sci U S A; 2012 Feb; 109(6):2078-83. PubMed ID: 22308455
[TBL] [Abstract][Full Text] [Related]
29. Cancer statistics, 2012.
Siegel R; Naishadham D; Jemal A
CA Cancer J Clin; 2012; 62(1):10-29. PubMed ID: 22237781
[TBL] [Abstract][Full Text] [Related]
30. Lower risk in parous women suggests that hormonal factors are important in bladder cancer etiology.
Davis-Dao CA; Henderson KD; Sullivan-Halley J; Ma H; West D; Xiang YB; Gago-Dominguez M; Stern MC; Castelao JE; Conti DV; Pike MC; Bernstein L; Cortessis VK
Cancer Epidemiol Biomarkers Prev; 2011 Jun; 20(6):1156-70. PubMed ID: 21493870
[TBL] [Abstract][Full Text] [Related]
31. Parity, early menopause and the incidence of bladder cancer in women: a case-control study and meta-analysis.
Dietrich K; Demidenko E; Schned A; Zens MS; Heaney J; Karagas MR
Eur J Cancer; 2011 Mar; 47(4):592-9. PubMed ID: 21067913
[TBL] [Abstract][Full Text] [Related]
32. Estrogen exposure and bladder cancer risk in Egyptian women.
Wolpert BJ; Amr S; Ezzat S; Saleh D; Gouda I; Loay I; Hifnawy T; Mikhail NN; Abdel-Hamid M; Zhan M; Zheng YL; Squibb K; Abdel-Aziz MA; Zaghloul M; Khaled H; Loffredo CA
Maturitas; 2010 Dec; 67(4):353-7. PubMed ID: 20813471
[TBL] [Abstract][Full Text] [Related]
33. Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells.
Chan KS; Espinosa I; Chao M; Wong D; Ailles L; Diehn M; Gill H; Presti J; Chang HY; van de Rijn M; Shortliffe L; Weissman IL
Proc Natl Acad Sci U S A; 2009 Aug; 106(33):14016-21. PubMed ID: 19666525
[TBL] [Abstract][Full Text] [Related]
34. Low-penetrance alleles predisposing to sporadic colorectal cancers: a French case-controlled genetic association study.
Küry S; Buecher B; Robiou-du-Pont S; Scoul C; Colman H; Le Neel T; Le Houérou C; Faroux R; Ollivry J; Lafraise B; Chupin LD; Sébille V; Bézieau S
BMC Cancer; 2008 Nov; 8():326. PubMed ID: 18992148
[TBL] [Abstract][Full Text] [Related]
35. Decreased bladder cancer growth in parous mice.
Johnson AM; O'Connell MJ; Messing EM; Reeder JE
Urology; 2008 Sep; 72(3):470-3. PubMed ID: 18533230
[TBL] [Abstract][Full Text] [Related]
36. Epidemiology of urinary bladder cancer: from tumor development to patient's death.
Murta-Nascimento C; Schmitz-Dräger BJ; Zeegers MP; Steineck G; Kogevinas M; Real FX; Malats N
World J Urol; 2007 Jun; 25(3):285-95. PubMed ID: 17530260
[TBL] [Abstract][Full Text] [Related]
37. Promotion of bladder cancer development and progression by androgen receptor signals.
Miyamoto H; Yang Z; Chen YT; Ishiguro H; Uemura H; Kubota Y; Nagashima Y; Chang YJ; Hu YC; Tsai MY; Yeh S; Messing EM; Chang C
J Natl Cancer Inst; 2007 Apr; 99(7):558-68. PubMed ID: 17406000
[TBL] [Abstract][Full Text] [Related]
38. E-cadherin expression during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl) nitrosamine in rats.
Oliveira PA; Colaço A; De la Cruz LF; Lopes P; Lopes C
J Exp Clin Cancer Res; 2006 Sep; 25(3):425-32. PubMed ID: 17167984
[TBL] [Abstract][Full Text] [Related]
39. DNA content analysis, expression of Ki-67 and p53 in rat urothelial lesions induced by N-butyl-N-(4-hydroxybutyl) nitrosamine and treated with mitomycin C and bacillus Calmette-Guérin.
Oliveira PA; Palmeira C; Colaço A; de la Cruz LF; Lopes C
Anticancer Res; 2006; 26(4B):2995-3004. PubMed ID: 16886626
[TBL] [Abstract][Full Text] [Related]
40. Occupation and bladder cancer among men in Western Europe.
Kogevinas M; 't Mannetje A; Cordier S; Ranft U; González CA; Vineis P; Chang-Claude J; Lynge E; Wahrendorf J; Tzonou A; Jöckel KH; Serra C; Porru S; Hours M; Greiser E; Boffetta P
Cancer Causes Control; 2003 Dec; 14(10):907-14. PubMed ID: 14750529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
